Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2023-05-29 , DOI: 10.1111/apt.17601
Yun Kyu Lee ₁ , Bo Kyung Koo _{1,

2} , Sae Kyung Joo ₃ , Dong Hyeon Lee ₃ , Heejoon Jang ₃ , Jee Won Chai ₄ , Myoung Seok Lee ₄ , Si Won Jang ₄ , Young Ho So ₄ , Jeong Hwan Park ₅ , Mee Soo Chang ₅ , Won Kim _{1,

3} ,

Affiliation

Sarcopaenia is associated with advanced nonalcoholic fatty liver disease (NAFLD). However, the impact of the muscle mass categorised by muscle quality on fibrosis progression remains unclear.

中文翻译：